Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Bladder cancer presents significant clinical challenges due to its complex immune microenvironment and highly heterogeneous response to treatments. To create accurate, individualized models of disease progression, we first construct a system of Ordinary Differential Equations (ODEs) that captures tumor-immune interactions. We address the challenge of estimating unknown parameters by performing a r...
Accurately predicting chemotherapy response remains a major challenge in precision oncology. Although machine-learning models based on tumour omics data have shown promise, the majority of existing studies are trained and evaluated on pre-clinical cell-line datasets, leaving their clinical applicability insufficiently characterised. In this study, we systematically evaluate a range of transfer-lea...
Compared to immortalized cell lines, patient-derived organoids and other ex vivo models have been shown to better recapitulate patient responses to th...
In this paper, we present a novel and efficient framework for cross-modality medical image synthesis, developed for BraSyn-Task 8. Our method combines...
Whole-slide images (WSIs) from cancer patients contain rich information that can be used for medical diagnosis or to follow treatment progress. To aut...
Background: Pancreatic ductal adenocarcinoma is one of the most aggressive and lethal malignancies of the gastrointestinal tract. The poor prognosis i...
The tumor region plays a key role in pathological diagnosis. Tumor tissues are highly similar to precancerous lesions and non tumor instances often gr...
Lung cancer is the leading cause of cancer-related mortality worldwide, predominantly affects older individuals, with non-small cell lung cancer (NSCL...
Cancer evolution is driven by complex changes in gene expression as cells transition and change states during tumorigenesis. Single-cell RNA sequencin...
Melanoma brain metastases (MBM) are common and spatially heterogeneous lesions, complicating cohort-level analyses due to anatomical variability and d...
Aging of hematopoietic stem and progenitor cells (HSPCs) impairs regenerative capacity and predisposes to hematological diseases. Here, we constructed...
Current standard of care imaging practices cannot reliably differentiate among certain renal tumors such as benign oncocytoma and clear cell renal cel...
Widespread screening for Adolescent Idiopathic Scoliosis (AIS) is critical for timely intervention but is currently constrained by the radiation risks...
Developing T cell receptors (TCRs) with sufficiently high affinity for tumor antigens (TAs) remains a fundamental challenge in TCR-T immunotherapy. Ex...
Genetic variation can influence protein abundance through translation, yet this regulatory layer remains poorly defined. We developed a deep learning ...
Circulating tumor DNA (ctDNA) profiling from liquid biopsies is increasingly adopted as a minimally invasive solution for clinical cancer diagnostic a...
Aging is asynchronous across cells and organs, but whether plasma proteins can capture cell type-specific aging and predict disease and mortality rema...
Accurate prognosis for Glioblastoma (GBM) using deep learning (DL) is hindered by extreme spatial and structural heterogeneity. Moreover, inconsistent...
Histopathologic evaluation remains central to cancer diagnosis and treatment planning, yet the molecular programs underlying distinct tissue morpholog...
Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies, largely due to the absence of reliable early stage biomarkers. Here, we ...